Skip to main content
Clinical Trials/NCT05224817
NCT05224817
Unknown
Not Applicable

Prospective, Multicenter Derivation and Validation of a NECROtizing Soft Tissue Infections (NECROSIS) Score

Methodist Health System1 site in 1 country1,010 target enrollmentNovember 1, 2019
ConditionsNecrosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Necrosis
Sponsor
Methodist Health System
Enrollment
1010
Locations
1
Primary Endpoint
mortality length of time in hospital
Last Updated
4 years ago

Overview

Brief Summary

Primary Objective:

The primary objective of this study is to develop and validate a clinical risk index score for identifying NSTIs in emergency general surgery patients being evaluated for a severe skin and soft tissue infection.

Secondary Objectives:

To describe the contemporary microbiology of NSTIs and explore the effects on outcomes and to identify predictors of amputation and mortality.

Detailed Description

This study is designed as a multicenter, prospective, observational study. There will be no direct interaction with subjects and involves no interventions; study is conducted completely via review of electronic health records. Our site will only collect data from the Methodist Dallas Medical Center. We plan to complete the data collection and analysis by 12/30/2021.

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
January 30, 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All adult patients (age ≥18 years old and ≤89 years old) with suspected or confirmed NSTI

Exclusion Criteria

  • Age \<18 years old and age \> 89 years
  • Pregnancy
  • Prisoners
  • Below ankle diabetic foot infections complicated by peripheral vascular disease
  • Burn wounds

Outcomes

Primary Outcomes

mortality length of time in hospital

Time Frame: 30-90 days

Change in the presence of necrosis

Time Frame: up to 30 days

thrombosed vessels or absence of bleeding

Study Sites (1)

Loading locations...

Similar Trials